Pitavastatin was approved in Japan in 2003 and in the U.S. in 2009 it has gained attention for its potential anticancer effects, particularly in types like triple negative breast cancer and ovarian cancer. It is a member of the statin family which is known for its cholesterol lowering properties and effectively reducing the risk of cardiovascular diseases. As per study results it may promote apoptosis and induce autophagy in cancer cells While exhibiting selective toxicity toward tumor cells over healthy ones, featuring its promising role in future cancer therapies.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Chen, Y.-H., Wu, J.-X., Yang, S.-F., Wu, Y.-C. and Hsiao, Y.-H., 2024. Molecular mechanisms underlying the anticancer properties of pitavastatin against cervical cancer cells. International Journal of Molecular Sciences.
Home
